762 INDEX. 



PAGE 



Agglutinogens, or agglutinable substances 219 



Diffusibility of, 221 ; distribution of, 220 ; flagellar 

 and somatic, 221 ; multiplicity of, 221 ; resistance 

 of, to heat, 221 ; structure of. 222 ; see Agglutinins 

 and Agglutination. 



Agglutinoids 223 



Xessins 122, 336 

 gy (see Anaphylaxis). 



Alexins 150, 245 



Definition of, 150 ; identity of. with complement, 249, 

 250 ; nature and selective action of, 246 ; see Com- 

 plement. 

 Alkaloids. 



Failure to cause formation of antibodies, 342 ; state 

 of, within the cells, 342, 349. 



Amboceptoid 353 



Amboceptors 249, 256 



Absorption of, by cells, 259, 261, 347 ; bacteriolytic, 

 258 ; complementophilous haptophore of, 147; c'yto- 

 philous haptophore of, 262 ; formation of. 264 ; 

 formation following vaccination, 378 : hemolytic 

 256 ; influence in phagocytosis. 320 ; isolation of, 

 260 ; manner of action of with complement, 260 ; 



262, 351, 352 ; occurrence of, in animal secretions, 

 274 ; origin from leucocytes. 313. 320 : origin in 

 cholera. 320 ; receptors of the third order, 351 ; 

 sensitization by, 256. 257, 259 ; solutions of, 258 ; 

 specificity of. 266, 267 ; structure of, 262 ; synonyms 

 for, 262, 361 ; union with cells, nature of, 262, 



263. 347. 348; see Hemolysins (serum), Bacterio- 

 lysins, Cytotoxins and Venoms. 



Amelia coli. 



Discovery of, 686 ; pathogenicity of, 688 ; symbiosis 

 of, 687. 688 ; see Amebic dysentery. 



Ameba proteus 686 



Ameba. 



Cultivation and distribution of. 687 ; phagocytic 

 action of, 306 ; resistance of, 687 ; symbiosis, 687, 

 688. 



Amebic dysentery 686 



Anatomic changes in, 689 ; immunity to. 690 : liver 

 abscess in, 689 ; occurrence of, 689 ; prophylaxis, 

 689 ; see Amebse, and Ameba coli. 



Amibodiastase 306 



Amyloid degeneration, production of, by staphylococcus. 542 



Anaphylaxis. 



Acquired, 384 ; active, 384 ; anaphylactic shock, 392 ; 

 anaphylotoxin, 390 ; antianaphylactic state, 393 ; 

 antibody in, 388 ; antigen in, 385 ; complement in, 

 390 ; natural, 384 ; passive, 384 ; relation to revac- 

 cination. 381 ; relation to primary toxicity, 386 ; 

 relation to tuberculin, 395 ; relation to serum dis- 

 ease. 396; sensitization in, 386; theories of, 391. 



"Anatomic tubercle" (see Tuberculosis). 



Animals, susceptibility of, to. 



Actinomycosis, 631 ; anthrax, 494, 495 ; B. influenza, 

 565 ; B. melitensis, 500 ; cholera, 474 ; hydrophobia, 

 704, 705 ; leprosy, 618 ; Micrococcus catarrhalis, 

 551 ; Micrococcus meningitidis, 558 ; oidiomycosis, 

 639, 640 ; pneumococcus. 504 : pseudotuberculosis, 

 614 ; relapsing fever. 643 ; staphylococcus, 375, 376 ; 

 streptococcus, 543 ; syphilis, 648, 649 ; trypanosomi- 



